IN BRIEF: ImmuPharma forecasts ‘year of delivery’ in 2026
ImmuPharma PLC - London-based specialist drug discovery and development company - Chair Tim McCarthy produces open letter to shareholders, noting that resolutions relating to the...
Thu, 09/04/2026 - 18:54